Evidence map›Paper›PMID 38152367›Full record

ArticleFrontiers in oncology2023

Xunbo Zheng, Li Han, Jun Guan, Chenteng Chen, Yue Zhang, Jiali Zhang, Yiran Zhang, Siyao Liu, Junyan Su, Mengyuan Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Xunbo ZhengThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Li HanBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Jun GuanThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Chenteng ChenThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Yue ZhangBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Jiali ZhangBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Yiran ZhangBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Siyao LiuBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Junyan SuBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Mengyuan LiuBeijing ChosenMed Clinical Laboratory Co. Ltd., Beijing, China.
Hanxing HuangThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Kingmed Diagnostics · CNFujian Medical University · CNPutian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Methods: RT-qPCR was used to detect the mRNA expression of Results: Conclusions: Taken together,

Indexed as

cell cycleimmune featurelung adenocarcinomanomogramRNA metabolismTICRR

Identifiers

PMID38152367
PMCPMC10751343
OpenAlexW4389683597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.